Evidence map›Paper›PMID 37215496›Full record

ArticleOpen life sciences2023

Significant elevated CXCL14 and decreased IL-39 levels in patients with tuberculosis.

Min Ding, Hong-Xu Wang, Si-Jia Gao, Xiao-Fei Lai, An-Long Li, Jia-Jia Bao, Felycia-Fernanda Hosyanto, Lei Xu

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Open life sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Min DingDepartment of Respiratory, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China.
Hong-Xu WangDepartment of Laboratory Medicine, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China.
Si-Jia GaoPathogenic Biology Department, School of Basic Medicine, Chongqing Medical University, Chongqing 400016, China.
Xiao-Fei LaiDepartment of Laboratory Medicine, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China.
An-Long LiPathogenic Biology Department, School of Basic Medicine, Chongqing Medical University, Chongqing 400016, China.
Jia-Jia BaoHospital-Acquired Infection Control Department, First People's Hospital of Jintang County, Chengdu, 610499, China.
Felycia-Fernanda HosyantoDepartment of Clinical Medicine, Chongqing Medical University, Chongqing 400016, China.
Lei XuPathogenic Biology Department, School of Basic Medicine, Chongqing Medical University, Chongqing 400016, China.
Chongqing Medical University · CNFirst Affiliated Hospital of Chongqing Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To explore the serum levels of IL-39, CXCL14, and IL-19 in patients with tuberculosis (TB) along with their clinical significances and their concentration changes in macrophages after

Indexed as

BCGbiomarkerCXCL14cytokineIL-39tuberculosis

Identifiers

PMID37215496
PMCPMC10199325
OpenAlexW4377080172

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.